Mabcampath and cardiac failure Patient Reports February 11, 2012

Mabcampath Side Effects Report #6039680-6
Mabcampath side effect was reported by a Physician from FRANCE on Jan 09, 2009. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 01/03/2009.

Mabcampath Side Effects Report #6041871-5
Mabcampath side effect was reported by a Physician from FRANCE on Jan 09, 2009. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 01/03/2009.

Mabcampath Side Effects Report #6070449-2
Mabcampath side effect was reported by a Physician from FRANCE on Feb 05, 2009. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 01/03/2009.

Mabcampath Side Effects Report #6081141-2
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Feb 05, 2009. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: 30 MG SUBCUTANEOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.